Tapping into the Scandinavian market, Helloworld has acquired an interest in Norway-based Australiareiser, bringing its ResWorld platform to Europe
Following FY22 results for Telix Pharmaceuticals brokers remain Buy-rated in light of an extensive pipeline of new products under development
Amidst a sea of red, the Neuren share price has skyrocketed in recent days following a world first approval for the biotech’s treatment of Rett syndrome
Tim Boreham gets his teeth into the opportunity ahead for listed dental products company SDI
IVE Group continues to prove its strong market position, lifting guidance as integration of Ovato outperforms over the first half
Countering inflation by lifting prices seems easier-said-than-done for many a small-cap food producer, reports Tim Boreham
Hansen Technologies’ H1 missed the mark, but management remains confident all shall be better in the second half
Demand for PeopleIN’s services remains strong, with diversification allowing the company to benefit from sector strength moving forward, but investors are not buying it
Future-focused PWR Holdings spends big on first half investment, but should see a pay off in the second half as the company’s Aerospace and Defence division finds its feet
Market responds positively to a just in-line first half performance from GUD Holdings, driving a share price increase and improved confidence in the company’s outlook